380 related articles for article (PubMed ID: 33077661)
21. Antiviral treatment of cytomegalovirus infection: an update.
Härter G; Michel D
Expert Opin Pharmacother; 2012 Apr; 13(5):623-7. PubMed ID: 22299626
[TBL] [Abstract][Full Text] [Related]
22. Anticytomegalovirus Peptides Point to New Insights for CMV Entry Mechanisms and the Limitations of
Jackson JW; Hancock TJ; Dogra P; Patel R; Arav-Boger R; Williams AD; Kennel SJ; Wall JS; Sparer TE
mSphere; 2019 Feb; 4(1):. PubMed ID: 30760613
[TBL] [Abstract][Full Text] [Related]
23. Oral hexadecyloxypropyl-cidofovir therapy in pregnant guinea pigs improves outcome in the congenital model of cytomegalovirus infection.
Bravo FJ; Bernstein DI; Beadle JR; Hostetler KY; Cardin RD
Antimicrob Agents Chemother; 2011 Jan; 55(1):35-41. PubMed ID: 21078944
[TBL] [Abstract][Full Text] [Related]
24. Human neural progenitor cell models to study the antiviral effects and neuroprotective potential of approved and investigational human cytomegalovirus inhibitors.
Trevisan M; Pianezzola A; Onorati M; Apolloni L; Pistello M; Arav-Boger R; Palù G; Mercorelli B; Loregian A
Antiviral Res; 2024 Mar; 223():105816. PubMed ID: 38286212
[TBL] [Abstract][Full Text] [Related]
25. Assessment of UL56 Mutations before Letermovir Therapy in Refractory Cytomegalovirus Transplant Recipients.
Santos Bravo M; Tilloy V; Plault N; Palomino SS; Mosquera MM; Navarro Gabriel M; Fernández Avilés F; Suárez Lledó M; Rovira M; Moreno A; Linares L; Bodro M; Hantz S; Alain S; Marcos MÁ
Microbiol Spectr; 2022 Apr; 10(2):e0019122. PubMed ID: 35343771
[No Abstract] [Full Text] [Related]
26. [Histologic change in human cytomegalovirus-infected explants of first trimester human placenta and expression of human cytomegalovirus gene].
Zhang Y; Wen LZ
Zhonghua Fu Chan Ke Za Zhi; 2005 Nov; 40(11):743-6. PubMed ID: 16324247
[TBL] [Abstract][Full Text] [Related]
27. Targeting the Host Mitochondria as a Novel Human Cytomegalovirus Antiviral Strategy.
Bachman LO; Zwezdaryk KJ
Viruses; 2023 Apr; 15(5):. PubMed ID: 37243170
[TBL] [Abstract][Full Text] [Related]
28. Study of human cytomegalovirus replication in body fluids, placental infection, and miscarriage during the first trimester of pregnancy.
Yan XC; Wang JH; Wang B; Huang LL; Zhou LQ; Zhu B; Liang Y
J Med Virol; 2015 Jun; 87(6):1046-53. PubMed ID: 25732959
[TBL] [Abstract][Full Text] [Related]
29. Drug targets in cytomegalovirus infection.
Andrei G; De Clercq E; Snoeck R
Infect Disord Drug Targets; 2009 Apr; 9(2):201-22. PubMed ID: 19275707
[TBL] [Abstract][Full Text] [Related]
30. The discovery and development of filociclovir for the prevention and treatment of human cytomegalovirus-related disease.
Hussein ITM; Brooks J; Bowlin TL
Antiviral Res; 2020 Apr; 176():104710. PubMed ID: 31940473
[TBL] [Abstract][Full Text] [Related]
31. Modeling of human cytomegalovirus maternal-fetal transmission in a novel decidual organ culture.
Weisblum Y; Panet A; Zakay-Rones Z; Haimov-Kochman R; Goldman-Wohl D; Ariel I; Falk H; Natanson-Yaron S; Goldberg MD; Gilad R; Lurain NS; Greenfield C; Yagel S; Wolf DG
J Virol; 2011 Dec; 85(24):13204-13. PubMed ID: 21976654
[TBL] [Abstract][Full Text] [Related]
32. Zika Virus Infects Early- and Midgestation Human Maternal Decidual Tissues, Inducing Distinct Innate Tissue Responses in the Maternal-Fetal Interface.
Weisblum Y; Oiknine-Djian E; Vorontsov OM; Haimov-Kochman R; Zakay-Rones Z; Meir K; Shveiky D; Elgavish S; Nevo Y; Roseman M; Bronstein M; Stockheim D; From I; Eisenberg I; Lewkowicz AA; Yagel S; Panet A; Wolf DG
J Virol; 2017 Feb; 91(4):. PubMed ID: 27974560
[TBL] [Abstract][Full Text] [Related]
33. Management of Cytomegalovirus Infections in the Era of the Novel Antiviral Players, Letermovir and Maribavir.
Piret J; Boivin G
Infect Dis Rep; 2024 Jan; 16(1):65-82. PubMed ID: 38247977
[TBL] [Abstract][Full Text] [Related]
34. The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo.
Kaptein SJ; Efferth T; Leis M; Rechter S; Auerochs S; Kalmer M; Bruggeman CA; Vink C; Stamminger T; Marschall M
Antiviral Res; 2006 Feb; 69(2):60-9. PubMed ID: 16325931
[TBL] [Abstract][Full Text] [Related]
35. Letermovir and Maribavir for the Treatment and Prevention of Cytomegalovirus Infection in Solid Organ and Stem Cell Transplant Recipients.
Imlay HN; Kaul DR
Clin Infect Dis; 2021 Jul; 73(1):156-160. PubMed ID: 33197929
[TBL] [Abstract][Full Text] [Related]
36. Predictive efficacy of SCID-hu mouse models for treatment of human cytomegalovirus infections.
Kern ER; Rybak RJ; Hartline CB; Bidanset DJ
Antivir Chem Chemother; 2001; 12 Suppl 1():149-56. PubMed ID: 11594682
[TBL] [Abstract][Full Text] [Related]
37. Cyclic cidofovir (cHPMPC) prevents congenital cytomegalovirus infection in a guinea pig model.
Schleiss MR; Anderson JL; McGregor A
Virol J; 2006 Mar; 3():9. PubMed ID: 16509982
[TBL] [Abstract][Full Text] [Related]
38. Prevention of congenital cytomegalovirus complications by maternal and neonatal treatments: a systematic review.
Hamilton ST; van Zuylen W; Shand A; Scott GM; Naing Z; Hall B; Craig ME; Rawlinson WD
Rev Med Virol; 2014 Nov; 24(6):420-33. PubMed ID: 25316174
[TBL] [Abstract][Full Text] [Related]
39. Fast selection of maribavir resistant cytomegalovirus in a bone marrow transplant recipient.
Schubert A; Ehlert K; Schuler-Luettmann S; Gentner E; Mertens T; Michel D
BMC Infect Dis; 2013 Jul; 13():330. PubMed ID: 23870704
[TBL] [Abstract][Full Text] [Related]
40. Primary Human Cytomegalovirus (HCMV) Infection in Pregnancy.
Buxmann H; Hamprecht K; Meyer-Wittkopf M; Friese K
Dtsch Arztebl Int; 2017 Jan; 114(4):45-52. PubMed ID: 28211317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
